6533b832fe1ef96bd129aece
RESEARCH PRODUCT
Dexamethasone and oxygen therapy in care home residents with diabetes: a management guide and algorithm for treatment: a rapid response action statement from the European Diabetes Working Party for Older People (EDWPOP) and European Geriatric Medicine Society (EuGMS)
Leocadio Rodríguez-mañasIsabelle Bourdel-marchassonStefania MaggiAhmed H AbdelhafizNicola VeroneseAlan J Sinclairsubject
Agingmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Statement (logic)medicine.medical_treatmentDiabeteDexamethasone03 medical and health sciencesLong-term care0302 clinical medicineDiabetes mellitusOxygen therapy80 and overDiabetes MellitusMedicineHumans030212 general & internal medicineConsensus DocumentRapid responseAgedGeriatricsAged 80 and overbusiness.industrySARS-CoV-2DiabetesCOVID-19medicine.diseaseCOVID-19 Drug TreatmentOxygenLong-term careAction (philosophy)Family medicineOxygen.Geriatrics and Gerontologybusiness030217 neurology & neurosurgeryAlgorithmsCOVID-19; Dexamethasone; Diabetes; Long-term care; Oxygen; Aged; Aged 80 and over; Algorithms; Dexamethasone; Humans; Oxygen; SARS-CoV-2; COVID-19; Diabetes Mellitusdescription
AbstractThis statement addresses the need to provide clinically relevant and practical guidance for long-term care staff working in care homes and other stakeholders engaged in the care of residents who require consideration for dexamethasone and oxygen therapy. It had been provided following a series of consensus discussions between the EDWPOP and the EuGMS in January and February 2021. Its main aim is to minimise morbidity and mortality from serious acute illnesses including COVID-19 requiring these treatments within the long-term care sector.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-04-01 | Aging Clinical and Experimental Research |